 "FDA grants priority review for Alzheimer's drug Lecanemab, say Eisai, Biogen")
Tokyo: Japanese drugmaker Eisai Co Ltd and its US partner Biogen Inc said on Monday that the US Food and Drug Administration granted priority review for traditional approval of their Alzheimer’s treatment Lecanemab. The FDA accepted Eisai’s supplemental Biologics License Application for the drug, supporting the transition from the accelerated approval granted in January, the drugmaker said in a statement. Read all the Latest News , Trending News , Cricket News , Bollywood News , India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.
End of Article
 "Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?")
 "As Russia pushes east, Ukraine faces mounting pressure to defend its heartland")
 "Why Mossad was not on board with Israel’s strike on Hamas in Qatar")
 "Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe")
 "Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?")
 "As Russia pushes east, Ukraine faces mounting pressure to defend its heartland")
 "Why Mossad was not on board with Israel’s strike on Hamas in Qatar")
 "Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe")
